Malaria Consortium in collaboration with Medicine for Malaria Ventures (MMV) and the Government of Nigeria implemented the project on Improving Severe Malaria Outcomes (ISMO), funded by UNITAID between July and and June 2016 to reduce mortality from severe malaria through the accelerated global adoption of injectable artesunate.
This Learning Brief outlines the outcomes of the project in three states in NIgeria, including the increase in adoption of Inj AS. It highlights the lessons from a mix of strategies including advocating for an enabling policy environment through policy and treatment guideline reviews; training of health workers; stocking of hospitals with injectable artesunate; conducting supportive supervision for health workers; and monitoring and evaluation.
Country: NigeriaKeywords: Treatment
« Back to Publications